Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 1,073.95
-1.75 (-0.16%)
Nov 12, 2026, 3:29 PM IST
Sakar Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,018 | 2,517 | 1,776 | 1,534 | 1,334 | 1,282 |
Other Revenue | 9.77 | 9.77 | 5.22 | 8.16 | 8.33 | 8.91 |
| 3,028 | 2,527 | 1,781 | 1,542 | 1,342 | 1,291 | |
Revenue Growth | 48.09% | 41.89% | 15.53% | 14.89% | 3.93% | 35.47% |
Cost of Revenue | 1,459 | 1,249 | 824.14 | 842.09 | 737.45 | 748.77 |
Gross Profit | 1,569 | 1,278 | 956.93 | 699.59 | 604.47 | 542.41 |
Selling, General & Admin | 442 | 388.74 | 317.32 | 198.62 | 169.35 | 153.55 |
Other Operating Expenses | 209.3 | 186.57 | 133.66 | 106.73 | 94.1 | 85.81 |
Operating Expenses | 905.83 | 810.96 | 659.8 | 485.85 | 413.3 | 336.04 |
Operating Income | 663.52 | 467.06 | 297.13 | 213.73 | 191.17 | 206.38 |
Interest Expense | -77.07 | -77.02 | -78.97 | -67.45 | -54.88 | -25.88 |
Interest & Investment Income | 2.53 | 2.53 | 0.18 | 1.25 | 3.93 | 0.56 |
Currency Exchange Gain (Loss) | 10.58 | 10.58 | 7.4 | 17.23 | 34.49 | 11.62 |
Other Non Operating Income (Expenses) | -3.43 | -5.59 | -6.57 | -8.71 | -4.75 | -3.22 |
EBT Excluding Unusual Items | 596.14 | 397.55 | 219.18 | 156.06 | 169.96 | 189.46 |
Gain (Loss) on Sale of Investments | - | - | - | 2.94 | - | 0.62 |
Gain (Loss) on Sale of Assets | - | - | -3.39 | - | - | - |
Other Unusual Items | - | - | -0.51 | - | -0.05 | - |
Pretax Income | 596.14 | 397.55 | 215.27 | 159 | 169.91 | 190.08 |
Income Tax Expense | 167.48 | 92.71 | 40.25 | 42.29 | 42.33 | 37.65 |
Net Income | 428.65 | 304.85 | 175.02 | 116.71 | 127.59 | 152.43 |
Net Income to Common | 428.65 | 304.85 | 175.02 | 116.71 | 127.59 | 152.43 |
Net Income Growth | 119.77% | 74.18% | 49.96% | -8.53% | -16.30% | 42.69% |
Shares Outstanding (Basic) | 22 | 22 | 22 | 21 | 19 | 15 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 21 | 19 | 15 |
Shares Change | 0.54% | 1.38% | 5.52% | 11.49% | 23.33% | - |
EPS (Basic) | 19.32 | 13.75 | 8.03 | 5.64 | 6.86 | 10.11 |
EPS (Diluted) | 19.32 | 13.75 | 8.00 | 5.63 | 6.86 | 10.11 |
EPS Growth | 118.59% | 71.81% | 42.11% | -17.95% | -32.13% | 42.69% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 191.31 | 209.06 | 17.5 | -350.93 | -488.51 | -109.08 |
Free Cash Flow Per Share | 8.63 | 9.43 | 0.80 | -16.93 | -26.27 | -7.24 |
Gross Margin | 51.83% | 50.57% | 53.73% | 45.38% | 45.05% | 42.01% |
Operating Margin | 21.91% | 18.48% | 16.68% | 13.86% | 14.25% | 15.98% |
Profit Margin | 14.16% | 12.06% | 9.83% | 7.57% | 9.51% | 11.80% |
Free Cash Flow Margin | 6.32% | 8.27% | 0.98% | -22.76% | -36.40% | -8.45% |
EBITDA | 891.59 | 676.25 | 496.85 | 393.27 | 341.03 | 279.66 |
EBITDA Margin | 29.44% | 26.76% | 27.90% | 25.51% | 25.41% | 21.66% |
D&A For EBITDA | 228.07 | 209.19 | 199.72 | 179.54 | 149.86 | 73.28 |
EBIT | 663.52 | 467.06 | 297.13 | 213.73 | 191.17 | 206.38 |
EBIT Margin | 21.91% | 18.48% | 16.68% | 13.86% | 14.25% | 15.98% |
Effective Tax Rate | 28.09% | 23.32% | 18.70% | 26.60% | 24.91% | 19.81% |
Revenue as Reported | 3,043 | 2,540 | 1,789 | 1,565 | 1,380 | 1,304 |
Advertising Expenses | - | 0.03 | 0.07 | 0.07 | 0.28 | 0.22 |